Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
European Archives of Psychiatry and Clinical Neuroscience|October 21, 2010
Anticholinergic drug use and risk for dementia: target for dementia preventionFrank Jessen, Hanna Kaduszkiewicz, Moritz Daerr, et al.
Clinical Pharmacology and Therapeutics|September 5, 2018
Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals?Hans-Georg Eichler, Brigitte Bloechl-Daum, Karl Broich, et al.
Neuroscience|April 29, 2019
Cav3.2 T-Type Calcium Channels Are Physiologically Mandatory for the Auditory SystemAndreas Lundt, Robin Seidel, Julien Soós, et al.
The European Journal of Neuroscience|October 12, 2019
Functional implications of Cav 2.3 R-type voltage-gated calcium channels in the murine auditory system - novel vistas from brainstem-evoked response audiometryAndreas Lundt, Julien Soós, Robin Seidel, et al.
Plos One|February 7, 2024
Sex- and region-specific cortical and hippocampal whole genome transcriptome profiles from control and APP/PS1 Alzheimer's disease miceAnna Papazoglou, Christina Henseler, Sandra Weickhardt, et al.
Neural Plasticity|April 18, 2015
Limited effects of an eIF2αS51A allele on neurological impairments in the 5xFAD mouse model of Alzheimer's diseaseKatharina Paesler, Kan Xie, Moritz M Hettich, et al.
Nature Reviews. Drug Discovery|July 2, 2010
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectivesHarald Hampel, Richard Frank, Karl Broich, et al.
Neuropharmacology|May 15, 2020
Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discoveryHarald Hampel, Andrea Vergallo, Filippo Caraci, et al.
Biochemical Pharmacology|November 27, 2013
Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020Harald Hampel, Simone Lista, Stefan J Teipel, et al.
Dialogues in Clinical Neuroscience|October 23, 2019
Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer's diseaseHarald Hampel, Andrea Vergallo, Mohammad Afshar, et al.
Pageof 9